NHG-guideline acute cough;NHG-standaard acuut hoesten

Huisarts en Wetenschap

Volumn 54, Issue 2, 2011, Pages 68-92

  Verheij, Th J M ^a   Hopstaken, R M ^a   Prins, J M ^a   Salome Ph L ^a   Bindels, P J ^a   Ponsioen, B P ^a   Sachs, A P E ^a   Thiadens, H A ^a   Verlee, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BUDESONIDE; C REACTIVE PROTEIN; CODEINE; DEXAMETHASONE; DOXYCYCLINE; MACROLIDE; NOSCAPINE;

ACUTE COUGH; ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASTHMA; BACTERIAL INFECTION; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFUSION; CONGESTIVE HEART FAILURE; COUGHING; COXIELLA BURNETII; CROUP; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; GESTATIONAL AGE; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; KIDNEY FAILURE; LEGIONELLA; LUNG AUSCULTATION; LUNG INFILTRATE; MEDICAL DECISION MAKING; NEUROLOGIC DISEASE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PEDIATRICIAN; PERTUSSIS; PNEUMONIA; PRACTICE GUIDELINE; PREGNANT WOMAN; Q FEVER; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION;

EID: 79951836225     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (209)

1. Bij verwijzingen naar NHG-producten. www.nhg.org.
2. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004,328.791
3. Akkerman AE, Kuyvenhoven MM, Van der Wouden JC, Verheij TJ. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother 2005,56.930-6.
4. Albaum MN, Hill LC, Murphy M, Li YH, Fuhrman CR, Britton CA, et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest 1996,110:343-50. (Pubitemid 26269258)
5. Allegra L, Blasi F, Diano P, Cosentini R, Tarsia P, Confalonieri M, et al. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease. Respir Med 2005,99.742-7.
6. Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 2004;125:1335-42.
7. Almirall J, Bolibar I, Serra-Prat M, Roig J, Hospital I, Carandell E, et al New evidence of risk factors for community-acquired pneumonia. a population-based study Eur Respir J 2008,31:1274-84.
8. Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients. a cluster-randomized intervention study J Antimicrob Chemother 2007,60 638-44. (Pubitemid 47299881)
9. Altiner A, Wilm S, Daubener W, Bormann C, Pentzek M, Abholz HH, et al Sputum colour for diagnosis of a bacterial infection in patients with acute cough Scand J Prim Health Care 2009,27 70-3
10. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007,CD004404.
11. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis Diagnosis and management of bronchiolitis. Pediatrics 2006,118.1774-93
12. Andre M, Schwan A, Odenholt I. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned Scand J Infect Dis 2004;36 192-7.
13. Bakker W, Dijkman JH. Rhonchi en crepitaties. nomenclatuur en interpretatie. Ned Tijdschr Geneeskd 1990;134 477-80 (Pubitemid 20113950)
14. Bartlett JG Diagnostic test for etiologic agents of community-acquired pneumonia. Infect Dis Clin North Am 2004;18.809-27
15. Bjornson CL, Johnson DW. Croup Lancet 2008,371:329-39
16. Blasi F. Atypical pathogens and respiratory tract infections Eur Respir J 2004,24.171-81.
17. Blom D, Ermers M, Bont L, Van Aalderen WM, Van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007,CD004881.
18. Boersma WG, Daniels JM, Lowenberg A, Boeve WJ, Van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006,100.926-32.
19. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 2006,129 238S-49S
20. Bont J, Hak E, Hoes AW, MacFarlane JT, Verheij TJ. Predicting death in elderly patients with community-acquired pneumonia. a prospective validation study reevaluating the CRB-65 severity assessment tool Arch Intern Med 2008,168 1465-8.
21. Bont L, Van Aalderen WM, Versteegh J, Brus F, Draaisma JT, Pekelharing-Berghuis M, et al. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing Pediatr Infect Dis J 2001;20-277-82. (Pubitemid 32240267)
22. Bradley CP. Uncomfortable prescribing decisions: a critical incident study BMJ 1992;304:294-6
23. Braun BL, Fowles JB. Characteristics and experiences of parents and adults who want antibiotics for cold symptoms Arch Fam Med 2000,9.589-95.
24. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008.168 2000-7.
25. British Thoracic Society. BTS guidelines for the management of community acquired pneumonia in adults - update (2004). britthoracic.org.uk/Portals/0/ Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04 pdf.
26. Bruns AH, Oosterheert JJ, Prokop M, Lammers JW, Hak E, Hoepelman AI. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia Clin Infect Dis 2007,45 983-91.
27. Brusse-Keizer MG, Grotenhuis AJ, Kerstjens HA, Telgen MC, Van der Palen J, Hendrix MG, et al. Relation of sputum colour to bacterial load in acute exacerbations of COPD Respir Med 2009,103 601-6.
28. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats BMJ 1998a,317.637-42.
29. Butler CC, Rollnick S, Kinnersley P, Jones A, Stott N Reducing antibiotics for respiratory tract symptoms in primary care. consolidating 'why' and considering 'how'. Br J Gen Pract 1998b,48:1865-70.
30. Butler CC, Kinnersley P, Prout H, Rollnick S, Edwards A, Elwyn G. Antibiotics and shared decision-making in primary care. J Antimicrob Chemother 2001;48:435-40 (Pubitemid 32898819)
31. Butler CC, Rollnick S, Kinnersley P, Tapper-Jones L, Houston H. Communicating about expected course and re-consultation for respiratory tract infections in children: an exploratory study Br J Gen Pract 2004;54 536-8 (Pubitemid 38931351)
32. Cals JW, Boumans D, Lardinois RJ, Gonzales R, Hopstaken RM, Butler CC, et al. Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br J Gen Pract 2007a,57 942-7.
33. Cals JW, Scheppers NA, Hopstaken RM, Hood K, Dinant GJ, Goettsch H, et al. Evidence based management of acute bronchitis; sustained competence of enhanced communication skills acquisition in general practice. Patient Educ Couns 2007b,68 270-8. (Pubitemid 47554617)
34. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial BMJ 2009,338 b1374
35. Cals JW, Schot MJ, De Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 2010,8.124-33.
36. Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. Cochrane Database Syst Rev 2007;CD006088.
37. Chavannes NH. Pulse oximetry and respiratory disease in primary care. Prim Care Resp J 2003,2-3
38. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006,174 84-93 (Pubitemid 43955248)
39. Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0 6 mg/kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol 2007,71:473-7 (Pubitemid 46123585)
40. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough Lancet 2008;371:1364-74.
41. Coenen S, Van Royen P, Vermeire E, Hermann I, Denekens J. Antibiotics for coughing in general practice: a qualitative decision analysis. Fam Pract 2000;17:380-5.
42. Commissie Farmaceutische Hulp Farmacotherapeutisch Kompas 2009. Diemen. College voor zorgverzekeringen, 2010.
43. Corneli HM, Zorc JJ, Majahan P, Shaw KN, Holubkov R, Reeves SD, et al A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357.331-9.
44. Creer DD, Dilworth JP, Gillespie SH, Johnston AR, Johnston SL, Ling C, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax 2006,61:75-9. (Pubitemid 43106982)
45. Nederlands Bijwerkingen Centrum Lareb. Potentieel misbruik van dextromethorfan bevattende hoestmiddelen. Gebu 2005,39.142-143. gebu artsennet.nl/Archief/Tijdschriftartikel/Potentieel-misbruik-van-dextromethorfan- bevattende-hoestmid-delen.htm
46. CVZ. Farmaco Economisch rapport palivizumab (Synagis) (2006).www cvz.nl/binaries/live/CVZ-Internet/hst-content/nl/documenten/cfh-rapporten/2006/ cfh0609+palivizumab+synagis.pdf
47. Dahler-Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem 1997,43-2064-75 (Pubitemid 27497804)
48. De Greeff SC, Mooi FR, Schellekens JF, De Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008,27-218-23
49. De Greeff SC, De Melker HE, Mooi FR Kinkhoest in Nederland Ned Tijdschr Geneeskd 2010;154:A1383
50. De Kok ME, Mertens PL, Cuijpers CE, Swaen GM, Wesseling GJ, Broer J, et al. The rate of respiratory symptoms among primary school children in two Dutch regions. Eur J Pediatr 1996;155.506-11.
51. Delsing CE, Bleeker-Rovers CP, Nabuurs-Franssen M, Sprong T, Van der Ven AJ, Kullberg BJ Q-koorts, een potentieel ernstige ziekte. Ned Tijdschr Geneeskd 2009,153 652-7.
52. Dicpinigaitis PV. Angiotensin-Converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006,129 169S-73S.
53. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008;186.369-74.
54. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004,113:1007-15. (Pubitemid 38437353)
55. Dinant GJ, Spigt MG, Knottnerus JA Praktische epidemiologie. Maarssen: Elsevier gezondheidszorg, 2008.
56. Duffy DL, Mitchell CA. Lower respiratory tract symptoms in Queensland schoolchildren. risk factors for wheeze, cough and diminished ventilatory function. Thorax 1993;48.1021-4.
57. Duijvestijn YC, Mourdi N, Smucny J, Pons G, Chalumeau M. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev 2009,CD003124
58. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992;17:175-80.
59. El Moussaoui R, De Borgie CA, Van den Broek P, Hustinx WN, Bresser P, Van den Berk GE, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia. randomised, double blind study. BMJ 2006,332:1355.
60. El Solh AA, Aquilina AT, Gunen H, Ramadan F. Radiographic resolution of community-acquired bacterial pneumonia in the elderly J Am Geriatr Soc 2004,52 224-9.
61. Engstrom S, Molstad S, Lindstrom K, Nilsson G, Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care. Scand J Infect Dis 2004;36 213-8. (Pubitemid 38618385)
62. Esposito S, Tremolati E, Begliatti E, Bosis S, Gualtieri L, Principi N Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005,43.438-40.
63. Falk G, Fahey T. C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies Family Practice 2009,26.10-21.
64. Farha T, Thomson AH. The burden of pneumonia in children in the developed world Paediatr Respir Rev 2005,6 76-82.
65. Fifoot AA, Ting JY. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup. a randomized, double-blinded clinical trial. Emerg Med Australas 2007;19:51-8 (Pubitemid 46212262)
66. File TM, Jr., Madell LA, Tillotson G, Kostov K, Georgiev O. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia a randomized, multicentre, double-blind study. J Antimicrob Chemother 2007,60:112-20. (Pubitemid 47073284)
67. File TM, Garau J, Jacobs MR, Wynne B, Twynholm M, Berkowitz E. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains. Int J Antimicrob Agents 2005,25.110-9.
68. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336 243-50 (Pubitemid 27044625)
69. Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, et al. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med 2004;116 529-35. (Pubitemid 38452644)
70. Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children. a meta-analysis of 1230 children. Pediatr Infect Dis J 2008,27:95-9.
71. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 1997;49.1045-9.
72. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006,3 CD001266
73. Garcia-Vazquez E, Marcos MA, Mensa J, De Roux A, Puig J, Font C, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med 2004;164:1807-11. (Pubitemid 39215654)
74. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000;105.E44
75. Gaydos CA, Eiden JJ, Oldach D, Mundy LM, Auwaerter P, Warner ML, et al. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 1994;19 157-60.
76. Geelhoed GC, Macdonald WB. Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol 1995;20:355-61.
77. Geijer RMM. Ernstige pseudokroep: verwijzen of zelf steroïden toedienen? Huisarts Wet 1999,42 099-100.
78. Gendrel D, Raymond J, Moulin F, Iniguez JL, Ravilly S, Habib F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997;16 388-91.
79. Gergen PJ. Environmental tobacco smoke as a risk factor for respiratory disease in children. Respir Physiol 2001;128 39-46 (Pubitemid 32771691)
80. Gibson SP, Weir DC, Burge PS. A prospective audit of the value of fibre optic bronchoscopy in adults admitted with community acquired pneumonia Respir Med 1993,87:105-9.
81. Graffelman AW, Eekhof JAH, Knuistingh Neven A. Verkoudheid. Huisarts Wet 2002,45 85-7.
82. Graffelman AW, Knuistingh Neven A, Le Cessie S, Kroes AC, Springer MP, Van den Broek PJ. A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment. Br J Gen Pract 2004;54:20-4 (Pubitemid 38071837)
83. Graffelman AW, Le Cessie S, Knuistingh Neven A, Wilemssen FE, Zonderland HM, Van den Broek PJ. Can history and exam alone reliably predict pneumonia? J Fam Pract 2007;56.465-70.
84. Graffelman AW, Willemssen FE, Zonderland HM, Knuistingh Neven A, Kroes AC, Van den Broek PJ. Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice. Br J Gen Pract 2008;58.93-7.
85. Gupta SK, Sarosi GA The role of atypical pathogens in community-acquired pneumonia. Med Clin North Am 2001;85.1349-65, vii.
86. Güryay MS, Ceylan E, Gunay T, Karaduman S, Bengi F, Parlak I, et al. Can spirometry, pulse oximetry and dyspnea scoring reflect respiratory failure in patients with chronic obstructive pulmonary disease exacerbation? Med Princ Pract 2007,16 378-83.
87. Haberg SE, Stigum H, Nystad W, Nafstad P. Effects of pre- and postnatal exposure to parental smoking on early childhood respiratory health. Am J Epidemiol 2007;166 679-86 (Pubitemid 47347899)
88. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008,CD005976.
89. Hale KA, Isaacs D Antibiotics in childhood pneumonia. Paediatr Respir Rev 2006,7:145-51. (Pubitemid 43812271)
90. Hall CB. Respiratory syncytial virus: A continuing culprit and conundrum. J Pediatr 1999,135 2-7.
91. Harnden A, Grant C, Harrison T, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006,174-7. (Pubitemid 44406743)
92. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004,CD003123
93. Hay AD, Wilson AD. The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review. Br J Gen Pract 2002,52.401-9.
94. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H et al Etiology of childhood pneumonia: serologic results of a prospective, population-based study Pediatr Infect Dis J 1998;17.986-91.
95. Hoepelman IM, Van der Noordaa J, Sauerwein RW, Verbrugh HA. Microbiologie en Infectieziekten. Houten: Bohn Stafleu Van Loghum, 2002.
96. Holm A, Nexoe J, Bistrup LA, Pedersen SS, Obel N, Nielsen LP, et al Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract 2007;57:547-54 (Pubitemid 47039501)
97. Holmberg H, Kragsbjerg P. Association of pneumonia and lung cancer the value of convalescent chest radiography and follow-up. Scand J Infect Dis 1993;25.93-100
98. Holmes WF, MacFarlane JT, MacFarlane RM, Hubbard R. Symptoms, signs, and prescribing for acute lower respiratory tract illness. Br J Gen Pract 2001;51:177-81. (Pubitemid 32197358)
99. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53 358-64. (Pubitemid 36582092)
100. Hopstaken RM, Witbraad T, Van Engelshoven JM, Dinant GJ. Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections Clin Radiol 2004,59:743-52.
101. Hopstaken RM, Stobberingh EE, Knottnerus JA, Muris JW, Nelemans P, Rinkens PE, et al. Clinical items not helpful in differentiating viral from bacterial lower respiratory tract infections in general practice. J Clin Epidemiol 2005;58.175-83
102. Hopstaken RM, Coenen S, Butler CC, Nelemans P, Muris JW, Rinkens PE, et al. Prognostic factors and clinical outcome in acute lower respiratory tract infections: a prospective study in general practice. Fam Pract 2006,23 512-9.
103. Hopstaken RM, Cals JWL, Dinant G. Accuracy of lipopolysaccharide-binding protein (LBP) and fibrinogen compared to C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care. Prim Care Resp J 2009,18.227-230
104. Houston MS, Silverstein MD, Suman VJ Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study Arch Intern Med 1997;157:2190-5. (Pubitemid 27451144)
105. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995,20:1174-8
106. Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med 2000;343:1715-21.
107. Jansen AG, Sanders EA, Hoes AW, Van Loon AM, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J 2007;30:1158-66. (Pubitemid 351194764)
108. Jansveld CA, Bakker W, Braat MC. Rapport van de commissie Nomenclatuur Longgeluiden Ned Tijdschr Geneeskd 1991;135 2380-3.
109. Johansson A, Ludvigsson J, Hermansson G. Adverse health effects related to tobacco smoke exposure in a cohort of three-year olds. Acta Paediatr 2008,97.354-7.
110. Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup N Engl J Med 1998;339 498-503.
111. Jurado D, Munoz C, Luna JD, Munoz-Hoyos A. Is maternal smoking more determinant than paternal smoking on the respiratory symptoms of young children? Respir Med 2005,99.1138-44
112. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000;19.293-8.
113. Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006,19.546-57
114. Kauffmann F, Tager IB, Munoz A, Speizer FE. Familial factors related to lung function in children aged 6-10 years. Results from the PAARC epidemiologic study. Am J Epidemiol 1989,129 1289-99. (Pubitemid 19148469)
115. Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjala H. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996,51:185-9. (Pubitemid 26060656)
116. Kaye KS, Stalam M, Shershen WE, Kaye D. Utility of pulse oximetry in diagnosing pneumonia in nursing home residents. Am J Med Sci 2002;324 237-42. (Pubitemid 35278767)
117. Kelly AM, McAlpine R, Kyle E. How accurate are pulse oximeters in patients with acute exacerbations of chronic obstructive airways disease? Respir Med 2001,95:336-40 (Pubitemid 32624477)
118. Klassen TP, Craig WR, Moher D, Osmond MH, Pasterkamp H, Sutcliffe T, et al. Nebulized budesonide and oral dexamethasone for treatment of croup. a randomized controlled trial. JAMA 1998;279.1629-32.
119. KNCV Tuberculosefonds. Kerncijfers 2009
120. www knevtbe nl/Site/Components/SitePageCP/ShowPage.aspx?ItemID=b4f3c2e3- c90c-45cc-b3aa-355d2bbb47f8&SelectedMenultemID=ecd51df8-877d-4300-8164- d8a47cf-c94d1
121. KNCV Tuberculosefonds. Tuberculose in Nederland 2008, Surveillancerapport over de tuberculosesituatie in Nederland (2009)
122. Kneyber MCJ, Steyerberg EW, De Groot R, Moll HA. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 2000,89.654-60
123. Lagerstrom F, Fredlund H, Holmberg H Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care. Scand J Prim Health Care 2004,22.83-6.
124. Lahde S, Jartti A, Broas M, Koivisto M, Syrjala H. HRCT findings in the lungs of primary care patients with lower respiratory tract infection. Acta Radiol 2002,43:159-63
125. Langley JM, Halperin SA, Boucher FD, Smith B. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004,114 e96-101.
126. LCI/RIVM. Richtlijn infectieziekten: Tuberculose (2009). www.rivm nl/cib/infectieziekten-A-Z/infectieziekten/tuberculose/index.jsp.
127. LCI/RIVM. Richtlijn infectieziektebestrijding: Q-koorts (2010). www rivm.nl/cib/infectie-ziekten-A-Z/infectieziekten/Q-koorts/index.jsp#index-7.
128. Lee PCL, Jawad MS, Eccles R Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000,52.1137-42.
129. Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003,58.377-82
130. Loeb M, Neupane B, Walter SD, Hanning R, Carusone SC, Lewis D, et al. Environmental risk factors for community-acquired pneumonia hospitalization in older adults. J Am Geriatr Soc 2009,57:1036-40.
131. MacFarlane J, Holmes W, MacFarlane R, Britten N Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study Br Med J 1997a;315.1211.
132. MacFarlane J, Prewett J, Rose D, Gard P, Cunningham R, Saikku P et al. Prospective case-control study of role of infection in patients who reconsult after initial antibiotic treatment for lower respiratory tract infection in primary care. BMJ 1997b;315.1206-10.
133. MacFarlane J, Holmes W, Gard P, MacFarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56.109-14.
134. Maheshwai N Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis? Arch Dis Child 2007,92 271-3
135. Maimon N, Nopmaneejumruslers C, Marras TK. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Eur Respir J 2008;31:1068-76.
136. Margolis P, Gadomski A. Does this infant have pneumonia? JAMA 1998,279.308.
137. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996,101:508-15. (Pubitemid 126335971)
138. Melbye H, Straume B, Aasebo U, Brox J The diagnosis of adult pneumonia in general practice. The diagnostic value of history, physical examination and some blood tests. Scand J Prim Health Care 1988,6.111-7.
139. Melbye H, Straume B, Brox J. Laboratory tests for pneumonia in general practice. the diagnostic values depend on the duration of illness. Scand J Prim Health Care 1992,10 234-40.
140. Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med 1996,156 997-1003
141. Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J 2003,21 989-93. (Pubitemid 36675615)
142. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997;278:1440-5. (Pubitemid 27475974)
143. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005,330:456.
144. Mittl RL, Jr., Schwab RJ, Duchin JS, Coin JE, Albeida SM, Miller WT Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med 1994;149 630-5 (Pubitemid 24082218)
145. Moore M, Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev 2006;3 CD002870.
146. Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner G, et al. Predicting the duration of symptoms in lower respiratory tract infection. Br J Gen Pract 2008;58:88-92. (Pubitemid 351222893)
147. Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax 2006,61 Suppl 1:i1-24.
148. Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007,7:10.
149. Muris JWM. Auscultatie van de longen in de huisartspraktijk. Een literatuuroverzicht. Huisarts Wet 1990,33 258-62.
150. Nolt BR, Gonzales R, Maselli J, Aagaard E, Camargo CA, Jr., Metlay JP. Vital-sign abnormalities as predictors of pneumonia in adults with acute cough illness. Am J Emerg Med 2007,25 631-6 (Pubitemid 46990697)
151. Pakistan Multicentre Amoxycillin Short Course therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial Lancet 2002,360:835-41.
152. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004;CD004878
153. Pattenden S, Antova T, Neuberger M. Nikiforov B, De Sario M, Grize L, et al. Parental smoking and children's respiratory health: independent effects of prenatal and postnatal exposure. Tob Control 2006;15:294-301.
154. Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L. Berlin CM, Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007;161:1140-6
155. Pedersen LV, Dahl M, Falk-Petersen HE, Larsen SE. Inhaleret budesonid versus dexamethason i.m. til behandling af pseudocroup. Ugeskr Laeger 1998;160:2253-6.
156. Pepys MB. C-reactive protein fifty years on. Lancet 1981;1.653-7.
157. Pillay V, Swingler G Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2003,CD003257.
158. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009,360.2079-89
159. Ponsioen BP, Hop WC, Vermue NA, Dekhuijzen PN, Bohnen AM. Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J 2005,25.147-52.
160. Putto A, Ruuskanen O, Meurman O Fever in respiratory virus infections. Am J Dis Child 1986,140:1159-63. (Pubitemid 17174406)
161. Ree GH, Davis M Treatment of lobar pneumonia in Papua New Guinea: short course chemotherapy with penicillin or chloramphenicol. J Infect 1983,6.29-32.
162. RIVM. Legionellose (2010). www.rivm.nl/cib/infectieziekten-A-Z/ infectieziekten/legionellose/index jsp. 2010.
163. Rollnick S, Kinnersley P, Butler C. Context-bound communication skills training development of a new method. Med Educ 2002;36.377-83
164. Rome L, Murali G, Lippmann M Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am 2001;85.1511-30, xi.
165. Roorda RJ, Walhof CM, Brand PL. Behandeling van laryngitis subglottica (pseudokroep): Steroiden in plaats van stomen. Ned Tijdschr Geneeskd 1998,142:1658-62. (Pubitemid 28340408)
166. Russell K, Wiebe N, Saenz A, Ausejo SM, Johnson D, Hartling L, et al. Glucocorticoids for croup. Cochrane Database Syst Rev 2004,CD001955
167. Sachs AP, Koeter GH, Groenier KH, Van der Waaij D, Schiphuis J, Meyboom-de long B. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995,50 758-63.
168. Schers H, Bor H, Van den Hoogen H, Van Weel C. What went and what came? Morbidity trends in general practice from the Netherlands. Eur J Gen Pract 2008;14 Suppl 1:13-24.
169. Seamark DA, Backhouse SN, Powell R Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein. Ann Clin Biochem 2003,40:178-80.
170. Seppa Y, Bloigu A, Honkanen PO, Miettinen L, Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care Arch Intern Med 2001;161:2709-13.
171. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar - pediatric cough and cold medications. N Engl J Med 2007,357:2321-4. (Pubitemid 350223385)
172. Shvartzman P, Lieberman D, Tandeter H, Portugeiz E, Pshetizky Y, Sasson M, et al. Clinical and laboratory profile of febrile respiratory infections in general practice. J Am Board Fam Pract 2004;17:32-7
173. SIGN Bronchiolitis in children: a national clinical guideline (2006). Scottish Intercollegiate Guidelines Network. wwwsign.ac.uk/pdf/sign91.pdf.
174. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2006,3 CD001728.
175. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004;CD000245.
176. Smith SM, Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2008,CD001831.
177. Smucny J, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev 2006,CD001726.
178. Sparrow A, Geelhoed G Prednisolone versus dexamethasone in croup. a randomised equivalence trial. Arch Dis Child 2006,91:580-3.
179. Spurling GK, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007;CD005189
180. Stein PD, Terrin ML, Hales CA, Palevsky HI, Saltzman HA, Thompson BT, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991;100.598-603.
181. Stichting Werkgroep Antibioticabeleid (SWAB). Optimaliseren van het antibioticabeleid in Nederland VIII. Herziene SWAB-richtlijnen voor antimicrobiële therapie bij thuis-opgelopen pneumonie. Amsterdam: AMC, 2005.
182. Stichting Werkgroep Antibioticabeleid (SWAB). NethMap2009 wwwswab.nl/swab/cms3.nsf/viewdoc/20BCD3983B5C390AC12575850031D33D.
183. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117:1638-45 (Pubitemid 30413357)
184. Sutton DR, Wicks AC, Davidson L. One-day treatment for lobar pneumonia Thorax 1970;25 241-4.
185. Swingler GH, Zwarenstein M. Chest radiograph in acute respiratory infections. Cochrane Database Syst Rev 2008,CD001268.
186. Tanen DA, Trocinski DR. The use of pulse oximetry to exclude pneumonia in children. Am J Emerg Med 2002;20 521-3. (Pubitemid 35168157)
187. Taylor JA, Novack AH, Almquist JR, Rogers JE. Efficacy of cough suppressants in children [see comments]. J Pediatr 1993;122:799-802.
188. Teeratakulpisarn J, Limwattananon C, Tanupattarachai S, Limwattananon S, Teeratakulpisarn S, Kosalaraksa P. Efficacy of dexamethasone injection for acute bronchiolitis in hospitalized children. a randomized, double-blind, placebo-controlled trial. Pediatr Pulmonol 2007;42:433-9. (Pubitemid 46700941)
189. Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother 2004;54:515-23. (Pubitemid 39177479)
190. Thiadens HA, De Bock GH, Dekker FW, Huysman JA, Van Houwelingen JC, Springer MP, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study BMJ 1998;316:1286-90.
191. Tijdink JM, Blanken MO, Bont L. Nieuwe inzichten in epidemiologie en Pathogenese van infecties met respiratoir syncytieel virus. Tijdschrift voor Infectieziekten 2007,2.137-42.
192. Tokar B, Ozkan R, Ilhan H. Tracheobronchial foreign bodies in children. importance of accurate history and plain chest radiography in delayed presentation. Clin Radiol 2004;59 609-15. (Pubitemid 38950076)
193. Van de Nadort C, Smeets HM, Bont J, Zuithoff NP, Hak E, Verheij TJ. Prognosis of primary care patients aged 80 years and older with lower respiratory tract infection. Br J Gen Pract 2009,59 e110-e115
194. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/RIVM, 2004
195. Van der Meer V, Neven AK, Van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review BMJ 2005,331 26
196. Van Duijn H, Kuyvenhoven M, Welschen I, Den Ouden H, Slootweg A, Verheij T. Patients' and doctors' views on respiratory tract symptoms. Scand J Prim Health Care 2002;20:201-2. (Pubitemid 36109403)
197. Van Gageldonk-Lafeber AB, Heijen ML, Bartelds AI, Peters MF, Van der Plas SM, Wilbrink B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis 2005,41:490-7.
198. Van Kempen WR. Tuberculose in de huisartspraktijk. Huisarts Wet 2001;44 5-8.
199. Van Woensel JB, Van Aalderen WM, Kneyber MC, Heijnen ML, Kimpen JL. Bronchiolitis hospitalisations in the Netherlands from 1991 to 1999. Arch Dis Child 2002,86:370-1.
200. Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study Br J Gen Pract 2009,59 e329-e338.
201. Vos PK, Van Herwaarden CL. Fysische diagnostiek - percussie van de thorax. Ned Tijdschr Geneeskd 1999,143:1812-5. (Pubitemid 29426179)
202. Welschen I, Kuyvenhoven M, Hoes A, Verheij T. Antibiotics for acute respiratory tract symptoms: patients' expectations, GPs' management and patient satisfaction. Fam Pract 2004,21:234-7.
203. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007,26.293-9
204. Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child 1978,132.484-7
205. Widdicombe JG. Advances in understanding and treatment of cough. Monaldi Arch Chest Dis 1999,54 275-9.
206. World Health Organization. Acute respiratory infections in children: case management in small hospitals in developing countries. WHO/ARI/90 5 Genève: WHO, 1990
207. Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999,18.98-104.
208. Young B, Gleeson M. Cripps AW C-reactive protein: a critical review Pathology 1991;23:118-24.
209. Zaat JOM, Stalman WAM, Assendelft WJJ, Hoort, wie klopt daar? Een systematische literatuurstudie naar de waarde van anamnese en lichamelijk onderzoek bij verdenking op een pneumonie. Huisarts Wet 1998;41:461-9. (Pubitemid 128777889)